The fluoride monopoly in oral care is cracking

Nano-hydroxyapatite (n-Ha) has been the standard fluoride-free remineralising agent in Japan since the 1980s, where it was originally developed for NASA. In the US it has, until recently, been a niche wellness ingredient.

That has changed. Boka is now stocked in Target, Whole Foods and Erewhon. The active is showing up in dentist-office professional lines. And the argument that "there is no evidence it works" — the ADA's line for years — is becoming harder to defend against a growing body of independent clinical work.

The bigger shift is generational. Millennial and Gen Z parents are the first American cohort willing to reject fluoride at scale, and they are the ones now buying children's toothpaste. If n-Ha becomes the default for kids first, adult follows.